Literature DB >> 29040970

Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid.

Clara Schaffer1, Thierry Buclin, Francois R Jornayvaz, Simone Cazzaniga, Luca Borradori, Michel Gilliet, Laurence Feldmeyer.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29040970     DOI： 10.1159/000480498

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  8 in total

Review 1.  [Immunoadsorption in dermatology].

Authors:  Franziska Hübner; Michael Kasperkiewicz; Detlef Zillikens; Enno Schmidt
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

2.  Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.

Authors:  Sian-De Liu; Wei-Ti Chen; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

3.  Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid.

Authors:  Ágnes Kinyó; Anita Hanyecz; Zsuzsanna Lengyel; Dalma Várszegi; Péter Oláh; Csaba Gyömörei; Endre Kálmán; Tímea Berki; Rolland Gyulai
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

4.  Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19.

Authors:  Caren Droesch; Mytrang Hoang Do; Maria DeSancho; Eun-Ju Lee; Cynthia Magro; Joanna Harp
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

5.  Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.

Authors:  Olivier Gaudin; Vannina Seta; Marina Alexandre; Gérôme Bohelay; Françoise Aucouturier; Sabine Mignot-Grootenboer; Saskia Ingen-Housz-Oro; Céline Bernardeschi; Pierre Schneider; Benoît Mellottee; Frédéric Caux; Catherine Prost-Squarcioni
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

Review 6.  Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.

Authors:  Kaisa Tasanen; Outi Varpuluoma; Wataru Nishie
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 8.786

Review 7.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10

8.  More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study.

Authors:  Ralf J Ludwig; Khalaf Kridin; Sascha Ständer; Enno Schmidt; Detlef Zillikens
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.